Evolving treatment modalities for immune thrombocytopenia in adults

The management of patients with relapsed or refractory immune thrombocytopenia (ITP) remains challenging for hematologists. While there are a multitude of drugs available, it is largely an individualized management based on patient preferences, side effects, previous treatment received, and response...

Descripción completa

Detalles Bibliográficos
Autores principales: Khadka, Sushmita, Kasireddy, Vineela, Dhakal, Pravash Kumar, Dadiboyina, Chandrakala
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850435/
https://www.ncbi.nlm.nih.gov/pubmed/33552432
http://dx.doi.org/10.1080/20009666.2020.1843237
Descripción
Sumario:The management of patients with relapsed or refractory immune thrombocytopenia (ITP) remains challenging for hematologists. While there are a multitude of drugs available, it is largely an individualized management based on patient preferences, side effects, previous treatment received, and responses to them, comorbidities and cost associated with the treatment. We hereby review the newer approaches in the treatment of ITP.

Ejemplares similares